Muscle, joint & pain

What Regenerative Injections Are Actually Cleared to Do

Save

'Regenerative medicine' is a marketing phrase, not a regulatory category. Here is what the FDA framework actually covers, why PRP and most clinic stem-cell shots fall outside proven-and-approved, how to check a product's status on the FDA's own pages, and what the well-studied alternatives, the ones guidelines actually recommend, can and cannot do.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Are stem cell and PRP injections FDA approved?

In almost every case sold for joints, tendons, or the spine, no. Platelet-rich plasma is generally handled as a same-visit product made from your own blood, so it never goes through the premarket approval that proves a drug works. Injections advertised as 'stem cell therapy' for orthopedic conditions have, as a class, not cleared that bar either. What a clinic can legally offer and what the FDA has proven safe and effective are separate questions.

A treatment being available at a clinic is not the same as a treatment the FDA has approved as safe and effective for your condition.

The umbrella term for these products, whether PRP, concentrated cells, or tissue extracts, is orthobiologics: biological materials injected to try to influence healing. The way they are regulated, which is the whole of orthobiologic regulation, depends less on the marketing name than on how the material is processed and what it is used for.

What 'FDA approved' actually means for an injection

'FDA approved' is a specific legal status, and it always attaches to a specific use. A product is approved to treat a named condition, not approved in the abstract. For injections there are a few different situations, and telling them apart is most of the work. A word borrowed from a brochure ('registered', 'FDA-compliant', 'cleared') can sound like approval without being it.

FDA statusWhat it actually means
Approved (drug or biologic)Reviewed and found safe and effective for a named condition
Cleared (device)The kit, needle, or centrifuge may be marketed; the injected result is not proven to treat anything
Registered or listedA facility told the FDA it exists, with no review of any product's benefit
Same-procedure tissueYour own, minimally handled tissue used in a single visit, outside premarket approval entirely

The FDA publishes consumer information on cell-based and regenerative products and keeps searchable databases of what it has actually approved. That is where a status claim can be checked against the record rather than taken from a sales page.

Why PRP sits in a regulatory gray zone

PRP sits outside the usual approval process because of what it is: your own blood, drawn, spun in a centrifuge to concentrate platelets, and injected back the same visit. Because it is minimally manipulated and used in a single procedure, it generally falls under a same-surgical-procedure exception rather than the drug-and-biologic approval pathway. That is a statement about paperwork, not about whether it works.

Whether PRP helps a particular tendon or an arthritic knee is a question the evidence, not the regulatory category, has to answer, and that evidence is mixed and still maturing. A page devoted to the PRP evidence and what the better trials show is the right place to weigh does prp actually work. The regulatory answer here is narrower: not approved does not mean illegal, and available does not mean proven.

What the proven alternatives can and cannot do

When you set a regenerative injection beside the treatments that are well studied, the contrast is instructive. For knee osteoarthritis, orthopaedic guidance puts the strongest evidence behind exercise and physical therapy, anti-inflammatory medication, and weight loss 1. Rheumatology guidance agrees, naming education and structured land-based exercise as core treatments 2. For low back pain, national guidance likewise recommends non-drug care, staying active, exercise, and hands-on therapies, before medication or procedures 3.

Even the most studied injection, the corticosteroid shot, has real limits worth knowing. In a two-year trial, a cortisone injection into an arthritic knee every twelve weeks gave no more pain relief than salt water and was linked to greater cartilage loss than placebo 4. For sciatica, an epidural steroid injection produces small, short-term relief of leg pain and no meaningful long-term benefit 5. None of this makes injections useless. It means the bar an unproven injection is being compared against is itself a modest one, and that paying a premium for something less studied deserves scrutiny. Overuse of low-value injections and procedures is a documented, widespread problem 6.

Questions worth asking before you pay out of pocket

Because these injections are usually paid out of pocket, often several hundred to a few thousand dollars a session and typically not covered by insurance, a few questions protect both your health and your wallet. Asked plainly, they separate an evidence-based offer from a sales pitch.

  • Is this approved, cleared, or neither for my specific condition? Ask for the status in writing, then check it against the FDA's own pages.
  • What does the best evidence show for my problem, not testimonials, but trials? The dedicated review of stem cell injection evidence is a better guide than a clinic's own before-and-after photos.
  • What is the comparator? If guideline-recommended physical therapy has not had a fair trial, that is usually the first step, not the last resort.
  • How is it paid for? Many clinics are cash-pay; some musculoskeletal expenses qualify under an HSA or FSA, so it is worth checking hsa/fsa for msk care and getting an itemized receipt.

Taking a few weeks to gather this information rarely changes the course of a chronic joint or tendon problem, and it protects you from paying for the unproven.

Where regenerative injections may fit

The honest position is neither hype nor blanket dismissal. Regenerative injections may have a role for some people, usually after first-line care, meaning exercise, load management, and time, has been given a real trial, and as part of an informed, shared decision that names the cost and the uncertainty out loud. They are best understood as one step in a sequence of care, not a shortcut around it.

That framing also protects you from the two failure modes that matter: paying thousands for a shortcut that outpaces its evidence, and, at the other extreme, dismissing a reasonable option a trusted clinician raises after the basics have been tried. The regulatory answer, mostly not FDA-approved for these uses, is the beginning of that conversation, not the end of it.

Common questions

Usually not. Most insurers consider PRP and similar orthobiologic injections investigational for musculoskeletal conditions, so clinics commonly offer them as cash-pay. Costs often run from several hundred to a few thousand dollars per session. Some of these expenses may qualify under an HSA or FSA, so an itemized receipt and a check of your plan's rules are worth doing before you commit.

No. Registration or listing means a facility has told the FDA it exists and makes a product. It is not a review of whether any product is safe or effective for a condition. Approval and clearance are different, higher bars. Language like 'FDA registered' on a website is not evidence that a specific injection has been proven to treat your problem.

Many are offered, but that is not the same as being approved. The FDA has publicly warned about unproven stem-cell products marketed for orthopedic and other conditions, and enforcement has targeted some clinics. The safest move is to verify a product's actual status on the FDA's own consumer pages rather than relying on a clinic's marketing.

No. A cortisone shot delivers an anti-inflammatory steroid and is well studied, with known short-term benefits and real limits over time. PRP concentrates platelets from your own blood in the hope of influencing healing, and its evidence is far less settled. They work by different mechanisms and are not interchangeable, though both are injections into or around a joint or tendon.

The FDA maintains public, searchable databases of approved drugs and biologics and of cleared devices, along with consumer pages on regenerative and cell-based products. Searching by the product name, and noting whether it is 'approved' for a named condition versus merely 'cleared' or 'registered', tells you far more than a clinic's brochure. When in doubt, ask the clinic to point you to the record.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When an injection needs urgent attention

  • A joint that becomes hot, swollen, and increasingly painful in the days after an injection, especially with fever or chills
  • Spreading redness, warmth, drainage, or a red streak moving away from the injection site
  • Sudden severe pain, new numbness, or new weakness in the limb after a spinal or nerve-area injection

A hot, swollen, worsening joint with fever after an injection can signal a joint infection; that is treated as an emergency, so an emergency room or urgent care visit the same day is warranted.

This article is educational and is not medical advice. It cannot tell you whether a particular injection is right for you. Decisions about PRP, stem-cell, or steroid injections belong in a conversation with a licensed clinician who can examine you and review your history.

References

  1. 1.American Academy of Orthopaedic Surgeons (AAOS) (2021). Management of Osteoarthritis of the Knee (Non-Arthroplasty), Third Edition — Clinical Practice Guideline. AAOS. linkThat AAOS's 2021 guideline finds strong evidence for exercise and physical therapy, NSAIDs, and weight loss as first-line, non-surgical management of knee osteoarthritis.
  2. 2.Bannuru RR, Osani MC, Vaysbrot EE, et al. (2019). OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and Cartilage. linkThat OARSI names education and structured land-based exercise as core treatments for osteoarthritis of the knee and hip.
  3. 3.Qaseem A, Wilt TJ, McLean RM, Forciea MA (American College of Physicians) (2017). Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. doi:10.7326/M16-2367That the American College of Physicians recommends non-pharmacologic treatments first for acute, subacute, and chronic low back pain.
  4. 4.McAlindon TE, LaValley MP, Harvey WF, et al. (2017). Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. PMID 28510679That repeated intra-articular triamcinolone every 12 weeks for two years did not improve knee osteoarthritis pain versus saline and was associated with greater cartilage loss.
  5. 5.Pinto RZ, Maher CG, Ferreira ML, et al. (2012). Epidural Corticosteroid Injections in the Management of Sciatica: A Systematic Review and Meta-analysis. Annals of Internal Medicine. doi:10.7326/0003-4819-157-12-201212180-00564That epidural corticosteroid injections give small, short-term relief of leg pain in sciatica without meaningful long-term benefit.
  6. 6.Buchbinder R, van Tulder M, Öberg B, et al. (2018). Low back pain: a call for action. The Lancet. doi:10.1016/S0140-6736(18)30488-4That low-value care for low back pain, including unnecessary injections and procedures, is widespread and should be reduced.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy